Immunodrug nicotine addiction vaccine (Cytos/Novartis)

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameImmunodrug nicotine addiction vaccine (Cytos/Novartis)
Drug Alias Name免疫药尼古丁成瘾的疫苗 - Cytos/诺华NIC-002Nicotine-QβCYT002-NicQβ
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsSmoking CessationTobacco Use Disorder
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesGermany
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCytos Biotechnology AgKuros Biosciences
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovartis Pharma Ag
Active IndicationsN/A
Inactive IndicationsSmoking CessationTobacco Use Disorder

Other Information

ATC CodeN/A
Related LinksN/A